Epigral Limited — Others, 05-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

Epigral Limited has confirmed that funds raised through its Qualified Institutional Placement were used exactly as planned during the reported quarter. The Audit Committee has verified this disciplined capital deployment, ensuring resources support the company’s operational and strategic goals with no financial discrepancies. This clear alignment boosts shareholder confidence in management’s consistent fund utilization.